Spanish medicine price discounts kick in
This article was originally published in Scrip
Executive Summary
Obligatory 7.5% discounts on medicines in Spain, which came in to force on 1 June are already paying off for the government. This week it announced that the amount it paid per prescription had fallen by 6.2% in June 2010 compared with the previous June.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.